Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Apex Healthcare Bhd's share price for the quarter that ended in Mar. 2024 was RM2.95. Apex Healthcare Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 718.9 Mil. Therefore, Apex Healthcare Bhd's market cap for the quarter that ended in Mar. 2024 was RM2,120.6 Mil.
Apex Healthcare Bhd's quarterly market cap
declined
from Sep. 2023 (RM1,795.6 Mil) to Dec. 2023 (RM1,788.8 Mil) but then
increased
from Dec. 2023 (RM1,788.8 Mil) to Mar. 2024 (RM2,120.6 Mil).
Apex Healthcare Bhd's annual market cap
increased
from Dec. 2021 (RM1,280.9 Mil) to Dec. 2022 (RM1,681.1 Mil) and
increased
from Dec. 2022 (RM1,681.1 Mil) to Dec. 2023 (RM1,788.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Apex Healthcare Bhd's Enterprise Value for Today is RM1,737.1 Mil.
Apex Healthcare Bhd Market Cap Historical Data
The historical data trend for Apex Healthcare Bhd's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Apex Healthcare Bhd's Market Cap
For the Medical Distribution subindustry, Apex Healthcare Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Market Cap distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Market Cap falls into.
Apex Healthcare Bhd Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Apex Healthcare Bhd's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd (XKLS:7090) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Apex Healthcare Bhd Market Cap Related Terms
Thank you for viewing the detailed overview of Apex Healthcare Bhd's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Apex Healthcare Bhd (XKLS:7090) Business Description
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:7090 has been successfully added to your 